Structure Therapeutics Inc. (GPCR)
Market Closed
2 Mar, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
62. 90
-0.08
-0.13%
Pre Market
$
+1.1 +1.75% 64. 00
3.63B Market Cap
- P/E Ratio
- Div Yield
500,582 Volume
- Eps
$ 62.98
Previous Close Day Range
61.51 64.37
Year Range
13.22 94.9
Want to track GPCR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
GPCR earnings report is expected in 23 days (26 Mar 2026)
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 0.2 |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
GPCR Earnings Reports FAQ
What is the earnings per share (EPS) for GPCR?
EPS data for GPCR is currently not available, as Structure Therapeutics Inc has not reported recent earnings.
What is the company's earnings growth rate?
Structure Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-03-26, based on the GPCR's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings were 0.2 per share, reported on 2026-03-26. For dividend history, visit the GPCR Dividends page.
What is the price-to-earnings (P/E) ratio?
The price-to-earnings (P/E) ratio is 314.50, calculated based on the most recent stock price of $62.90.
